Jun 12, 2019 / 09:40PM GMT
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity Analyst
All right, I think we can look to get started. Thanks for being here. I'm Patrick Donnelly, a tools and diagnostics analyst here at Goldman. Happy to have Prahlad Singh, COO; and Jamey Mock, CFO of PerkinElmer with us today. Be about a 35-minute session. Certainly, open a Q&A, so if you have any questions, feel free to just raise your hand. But Prahlad, maybe to start, maybe you can just talk about how the year has gone so far. And we can kind of start high level there and then dive into the Q&A.
Prahlad R. Singh - PerkinElmer, Inc. - President & COO
Yes, sure. Thank you, Patrick. It's great to be here. I think before we talk about the year so far, I think one of the things that would be great to start off is recalibrate where we are from a company perspective. Over the past 4, 5 years, we sort of diligently tried to evolve our portfolio and go from one where we were more focused around instruments to one where instruments is now only one part of our business, and our
PerkinElmer Inc at Goldman Sachs Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
